BioMark Diagnostics Inc. (BUX.CN)
CAD 0.25
(0.0%)
CAD 0.25
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.08 Million CAD | 48.7% |
| 2022 | 732.29 Thousand CAD | -50.24% |
| 2021 | 1.47 Million CAD | 54.43% |
| 2020 | 952.93 Thousand CAD | 49.53% |
| 2019 | 637.29 Thousand CAD | 1739.66% |
| 2018 | 34.64 Thousand CAD | -33.05% |
| 2017 | 51.74 Thousand CAD | 30.76% |
| 2016 | 39.57 Thousand CAD | 17.19% |
| 2015 | 33.76 Thousand CAD | -85.34% |
| 2014 | 230.33 Thousand CAD | 150.36% |
| 2013 | 92 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1 Million CAD | -7.59% |
| 2023 Q4 | 1.08 Million CAD | -19.29% |
| 2023 Q1 | 722.8 Thousand CAD | -1.29% |
| 2023 FY | 1.08 Million CAD | 48.7% |
| 2023 Q2 | 632.23 Thousand CAD | -12.53% |
| 2023 Q3 | 1.34 Million CAD | 113.41% |
| 2022 Q4 | 732.29 Thousand CAD | -17.22% |
| 2022 Q3 | 884.59 Thousand CAD | -12.23% |
| 2022 Q2 | 1 Million CAD | -22.83% |
| 2022 Q1 | 1.3 Million CAD | -11.24% |
| 2022 FY | 732.29 Thousand CAD | -50.24% |
| 2021 Q1 | 758.16 Thousand CAD | -20.44% |
| 2021 Q2 | 629.55 Thousand CAD | -16.96% |
| 2021 FY | 1.47 Million CAD | 54.43% |
| 2021 Q3 | 1.39 Million CAD | 120.96% |
| 2021 Q4 | 1.47 Million CAD | 5.79% |
| 2020 Q3 | 404.19 Thousand CAD | -17.55% |
| 2020 Q4 | 952.93 Thousand CAD | 135.76% |
| 2020 Q1 | 533.28 Thousand CAD | -16.32% |
| 2020 Q2 | 490.21 Thousand CAD | -8.08% |
| 2020 FY | 952.93 Thousand CAD | 49.53% |
| 2019 Q2 | 79.82 Thousand CAD | -54.3% |
| 2019 Q1 | 174.66 Thousand CAD | 404.19% |
| 2019 FY | 637.29 Thousand CAD | 1739.66% |
| 2019 Q4 | 637.29 Thousand CAD | -14.23% |
| 2019 Q3 | 743.04 Thousand CAD | 830.85% |
| 2018 Q3 | 77.43 Thousand CAD | 67.02% |
| 2018 Q4 | 34.64 Thousand CAD | -55.26% |
| 2018 FY | 34.64 Thousand CAD | -33.05% |
| 2018 Q1 | 149.89 Thousand CAD | 189.67% |
| 2018 Q2 | 46.36 Thousand CAD | -69.07% |
| 2017 FY | 51.74 Thousand CAD | 30.76% |
| 2017 Q4 | 51.74 Thousand CAD | -64.89% |
| 2017 Q3 | 147.37 Thousand CAD | -50.94% |
| 2017 Q2 | 300.39 Thousand CAD | -36.57% |
| 2017 Q1 | 473.59 Thousand CAD | 1096.8% |
| 2016 Q1 | 25.16 Thousand CAD | -25.48% |
| 2016 FY | 39.57 Thousand CAD | 17.19% |
| 2016 Q2 | 16.59 Thousand CAD | -34.04% |
| 2016 Q4 | 39.57 Thousand CAD | 179.46% |
| 2016 Q3 | 14.16 Thousand CAD | -14.67% |
| 2015 Q1 | 79.93 Thousand CAD | -65.29% |
| 2015 Q3 | 44.46 Thousand CAD | -15.16% |
| 2015 Q4 | 33.76 Thousand CAD | -24.06% |
| 2015 FY | 33.76 Thousand CAD | -85.34% |
| 2015 Q2 | 52.4 Thousand CAD | -34.44% |
| 2014 FY | 230.33 Thousand CAD | 150.36% |
| 2014 Q2 | 1.00 CAD | 0.0% |
| 2014 Q3 | 142.07 Thousand CAD | 14207700.0% |
| 2014 Q4 | 230.33 Thousand CAD | 62.12% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 FY | 92 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Izotropic Corporation | 232.37 Thousand CAD | -368.603% |
| Sona Nanotech Inc. | 2.74 Million CAD | 60.378% |